Institute for International Research

See you April 5-8, 2010 in Shanghai, China!

The 4-day China 2009 Pharmaceutical R&D Summit ends on a high note!

Now in its 4th year, IBC's China Pharmaceutical R&D Summit has emerged as one of the leading high-level pharmaceutical business conferences in China, with attendance and participation of over 300 very senior executives from many top tier companies including Roche, Eli Lilly, Merck, AstraZeneca, GSK among others.

This year, the organizers have further partnered with Zhangjiang Group, the Pudong Science & Technology Commission as well as the ZJ Biotech & Pharmaceutical Base Development Co. todevelope a half-day pre-conference seminar. This special seminar featured several senior level government officials such as Dr. HongGuang Wang, Director of China National Center for Biotechnology Development; Mr. Endi Zhang, Deputy Governor of Pudong New District; Dr. Qingkui Zhang, State Intellectual Property Office of PR China; as well as Dr. Jianhua Ding, International Cooperation Department at State FDA. The outstanding seminar drew a large contingent of local and international companies interested in learning about Zhangjiang's global and local initiatives.

China's Largest Science Park Aims to Double Pharma Output In Three Years; Launches New Partnering Platform - Read More

The Main Conference opened with 3 incredible keynote presentations from:Dr. Lee Babiss, President and Global Head of Pharma Research at F. Hoffmann La-Roche Ltd.; Robert Armstrong, Vice President, Global External Research and Development, Eli Lilly & Co.; and Merv Turner, Chief Strategy Officer & SVP, Worldwide Licensing & External Research, Merck & Co. With presentations ranging from restructuring for innovation; developing R&D model in China and global partnering strategies, the 3 keynote addresses touched the core of what's happening in China today - the rise of innovation, the changing paradigms and the search for partnering. This sets the stage for the rest of the conference, which features topics on NCE discovery, preclinical development, industry-academic collaborations; clinical trials and new directions in antibody research and therapeutics.

Networking

Join our Linkedin Group, "China LifeSciences Network" to share your thoughts and ideas and continue to build up your network in an open online forum.

Registered Attendees of the 2009 Conference can continue to connect and communicate with other attendees:
Don't forget to log on to events.zerista.com/login and use the log in you were assigned when registering for the conference.